Merck Sharp & Dohme LLC recalls Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactur…

Recall date

December 12, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0242-2026

FDA classification

Class II

Brand / firm

Merck Sharp & Dohme LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

Presence of particulate matter: potential presence of metal particulates in the product.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.